Multiple Myeloma, Plasma Cell Leukemia
2 clinical trials · Condition
◉ Watch Multiple Myeloma, Plasma Cell Leukemia
| Record | Firm | Date |
|---|---|---|
| A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma (NCT01248923) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2010-12-01 |
Track Multiple Myeloma, Plasma Cell Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.